mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2013-01-16
DOI
10.1172/jci65086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
- (2012) Taru Muranen et al. CANCER CELL
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
- (2012) Andrew Jarnicki et al. Cell Division
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
- (2011) Arun K Mankan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- mTOR as a therapeutic target in patients with gastric cancer
- (2011) Salah-Eddin Al-Batran et al. INTERNATIONAL JOURNAL OF CANCER
- Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
- (2011) Seth A. Wander et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer
- (2011) I. Altomare et al. ONCOLOGIST
- Analysis of cellular phosphatidylinositol (3,4,5)-trisphosphate levels and distribution using confocal fluorescent microscopy
- (2010) Michelle Palmieri et al. ANALYTICAL BIOCHEMISTRY
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice
- (2010) Chong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
- (2010) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
- (2010) Tracy Putoczki et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
- (2010) S. S. Agarwala et al. ONCOLOGIST
- Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development
- (2010) A. M. Gustafson et al. Science Translational Medicine
- A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis
- (2009) Lin Deng et al. AMERICAN JOURNAL OF PATHOLOGY
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics
- (2009) Carlos M. Carvalho et al. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
- (2009) Chia Huey Ooi et al. PLoS Genetics
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mining for JAK–STAT mutations in cancer
- (2008) Stefan N. Constantinescu et al. TRENDS IN BIOCHEMICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now